Pfizer stated on September 25 that most of the production lines at its Rocky Mount, North Carolina plant in the United States have been restarted after suffering severe damage from a tornado strike on July 19.
This factory is one of the largest production bases for sterile injectable products globally. It produces nearly 30% of the sterile injectables used in U.S. hospitals and also focuses on manufacturing various products, including anti-infective drugs.